Key facts
- Cava CEO Brett Schulman noted an increase in adult customers ordering kids' meal portions.
- Schulman refers to these adult customers as 'big kids.'
- He attributes this trend to the use of GLP-1 weight-loss drugs.
- GLP-1 drugs are known to reduce appetite and food intake.
- Cava's menu offerings align with reduced portion size preferences.
- The casual dining chain is positioned to cater to this evolving consumer demand.
Cava CEO Brett Schulman has identified a notable trend within the casual dining chain: an increasing number of adult customers are ordering children's meal portions. Schulman refers to these patrons as 'big kids.' He attributes this phenomenon directly to the widespread use of GLP-1 weight-loss drugs, such as Ozempic and Wegovy. These medications are known to suppress appetite and reduce overall food consumption, leading individuals to seek smaller meal sizes. Cava's menu structure, which allows for customization and offers various portion options, is seen as an advantage in accommodating this emerging customer behavior. The company's offerings are aligning with the dietary needs and preferences of consumers who are experiencing reduced appetites due to these popular weight-loss treatments.